| Filed On | Filing |
|---|---|
| 20 Apr 2006 |
Form 4: Nomura International Plc, 10% owner and 3 others · Gyre Therapeutics, Inc.
Received 2,136,904 shares as a grant or award · Converted 14,834,710 Series C Convertible Preferred Stock |
| 01 Feb 2006 |
Form 4: Nomura International Plc, 10% owner and 1 other · Altus Pharmaceuticals Inc.
Received 1,522,280 shares by conversion · Acquired 224,183 shares (Other Transaction) |
Loading...
